SCHEMBL24101503

SCHEMBL24101503

CN(C)[C@H]1Cc2[nH]c3ccncc3c2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.39
HTR6 P50406 4/20 0.38
PARP1 P09874 1/20 0.36
HTR1F P30939 1/20 0.35
KIF11 P52732 1/20 0.35
CCNT1 O60563 1/20 0.35
CCNT2 O60583 1/20 0.35
CCNB2 O95067 1/20 0.35
CDK1 P06493 1/20 0.35
CCNB1 P14635 1/20 0.35
CCNA2 P20248 1/20 0.35
CDK2 P24941 1/20 0.35
CDK9 P50750 1/20 0.35
CCNA1 P78396 1/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35
MAPT P10636 3/20 0.34
FEN1 P39748 1/20 0.34
HTR1D P28221 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24101514 1.00 ACHE (0.39) ACHEHTR6PARP1HTR1FKIF11
SCHEMBL24101508 0.88 CHUK (0.39) PARP1KIF11HTR1DHTR1BKDM4E
SCHEMBL24101496 0.88 CHUK (0.39) PARP1KIF11HTR1DHTR1BKDM4E
SCHEMBL24101864 0.87 HTR1F (0.47) ACHEHTR6HTR1FMAPTHTR1D
SCHEMBL24101526 0.87 HTR1F (0.47) ACHEHTR6HTR1FMAPTHTR1D
SCHEMBL24101538 0.87 HTR1F (0.47) ACHEHTR6HTR1FMAPTHTR1D
SCHEMBL24101861 0.85 HTR1F (0.41) ACHEHTR6HTR1FHTR1DHTR1B
SCHEMBL24101499 0.85 HTR1F (0.41) ACHEHTR6HTR1FHTR1DHTR1B
SCHEMBL24101506 0.85 HTR1F (0.41) ACHEHTR6HTR1FHTR1DHTR1B
SCHEMBL24101511 0.76 HTR1F (0.45) HTR1FKIF11HTR1DHTR1BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227453-A1 TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-20 US disclosed
US-20230227453-A1 TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-20 US disclosed
WO-2021252691-A1 TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. (US) 2021-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227453-A1 TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF GAP43, GRIN2A, GRIN2C ACHE 77/4885HTR6 44/4885PARP1 2533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.